# Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 P&L / Income Statement

- Company: Kestra Medical Technologies, Ltd. (KMTS)
- Period: 2026-05-01 to 2026-07-31
- Filing: Q1 FY2026 10-Q, filed 2026-09-14, accession number 0001193125-26-390766
- Page: https://plicit.ai/financials/kmts/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/kmts-fy2026-q1-income-statement-sankey.png

## Chart details

Income statement for 2026-05-01 through 2026-07-31. Consolidated revenue, costs and expenses.

- **Revenue**: 30,971,000 US dollars
- **Cost of revenue**: 13,473,000 US dollars
- **Gross profit**: 17,498,000 US dollars
- **Total operating expenses**: 55,155,000 US dollars
- **Loss from operations**: negative 37,657,000 US dollars
- **Other income (expense), net (calculated)**: negative 6,380,000 US dollars
- **Net loss before provision for income taxes**: negative 44,037,000 US dollars
- **Provision for income taxes**: 50,000 US dollars
- **Net loss**: negative 44,087,000 US dollars
- **Undisclosed sources**: 30,971,000 US dollars. The filing reports revenue as one line and discloses no sources of it.
- **Research and development**: 6,796,000 US dollars
- **Selling, general and administrative**: 48,359,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.